Cue Biopharma, Inc. Increase (Decrease) in Other Operating Assets
Cue Biopharma, Inc. (CUE) reported Increase (Decrease) in Other Operating Assets of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2023-03-21
- Cue Biopharma, Inc. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was $0.00.
- Cue Biopharma, Inc. increase (decrease) in other operating assets for the quarter ending 2022-09-30 was $0.00.
- Cue Biopharma, Inc. increase (decrease) in other operating assets for the quarter ending 2021-12-31 was $0.00.
- Cue Biopharma, Inc. increase (decrease) in other operating assets for the quarter ending 2021-09-30 was $0.00.
- Cue Biopharma, Inc. increase (decrease) in other operating assets for fiscal 2022 was $0.00.
- Cue Biopharma, Inc. increase (decrease) in other operating assets for fiscal 2021 was -$250.00K, a 5129.17% decline from fiscal 2020.
- Cue Biopharma, Inc. increase (decrease) in other operating assets for fiscal 2020 was $4.97K.
- Cue Biopharma, Inc. increase (decrease) in other operating assets for fiscal 2019 was -$123.44K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $0.00 derived: sum of 2 quarters · filed 2023-03-21 | $0.00 10-K · filed 2023-03-21 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $0.00 derived: sum of 2 quarters · filed 2023-03-21 | $0.00 derived: sum of 3 quarters · filed 2023-03-21 | -$250.00K 10-K · filed 2023-03-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$250.00K 10-Q · filed 2022-11-14 | -$495.03K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$250.00K 10-Q · filed 2022-08-04 | -$495.03K derived: sum of 3 quarters · filed 2022-08-04 | |
| 2021-03-31 | -$250.00K 10-Q · filed 2022-05-10 | -$495.03K derived: sum of 2 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$245.03K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $4.97K 10-K · filed 2022-03-16 | ||
| 2020-09-30 | $250.00K 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | -$115.44K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$123.44K 10-K · filed 2021-03-09 | ||
| 2019-09-30 | -$8.00K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |